Impact Factor
3.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.17
325 total citations
h5-index
29
h5 depth signal
Cited share
84.1%
74 of 88
Total citations
325
Citation footprint
Metric signal
3.64
External metric anchor
Self-citation
0.6%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
252
China
141
India
134
Germany
99
United Kingdom
58
Citing Fields of Research
Protein Structure & Folding
644
AI & Machine Learning
214
Physical Chemistry
137
Drug Delivery Systems
77
Cell Biology
74
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,907
Articles tracked across the journal lifetime
Indexed publication set
88
74 cited publications
Last 12 months
277
23.1 publications/month
Open access share
19.1%
53 OA publications in the last year
Leading citing country
United States
252 citing publications
Leading citing field
Protein Structure & Folding
644 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Apr. 1987-
v1n1, Apr. 1987-
Active Coverage
Research Focus & Classification
Indexed Subjects
Protein Structure & Folding
AI & Machine Learning
Neurodegenerative Disorders
Diabetes
Phytochemicals
Synthesis
Broad Categories
Biomedical Engineering
Molecular Biology
Protein Structure & Folding
MeSH Descriptors
Computer Simulation
Molecular Biology
Molecular Conformation
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10822-026-00964-6
Open DOI
Exploring the pharmacological basis of adverse effects in oxazolidinone and antidepressant cotherapy: an in silico study
02
DOI 10.1007/s10822-026-00959-3
Open DOI
MGCLSyn: multimodal graph contrastive learning for drug synergy prediction
03
04
05
DOI 10.1007/s10822-026-00952-w
Open DOI
Toward FOXM1 inhibitors based on supervised machine learning classification models and similarity-based screening
06
DOI 10.1007/s10822-026-00956-6
Open DOI
DeepFusion-ACSM: an interpretable hybrid ML-DL ensemble model for anticancer small-molecule activity prediction
07
08
DOI 10.1007/s10822-026-00954-8
Open DOI
Are QM/MM models systematically improvable? A case study on carbonic anhydrase binding affinities
09
DOI 10.1007/s10822-026-00957-5
Open DOI
Automated pharmacophore hypothesis generator for SILCS-Pharm: ph4gen
10
Bibliographical & Catalog Notes
Latest issue consulted: surrogate of Vol. 16, no. 5/6 (May/June 2002).
Also issued online.
Absorbed: Perspectives in drug discovery and design, Jan. 2001, which had formerly been a supplement to this title.